Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (NYSE:GSK)

40.76
Delayed Data
As of Feb 05
 -0.22 / -0.54%
Today’s Change
37.24
Today|||52-Week Range
49.08
+1.02%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Revenue and IncomeNet Revenues9.7B8.5B9.1B9.4B
 
 
 
 
 
Cost of Goods Sold1.9B2.3B1.8B2.8B
 
 
 
 
 
Depreciation And Amortization1.1B584.6M1.1B359.8M
 
 
 
 
 
 
Operating ExpensesGross Income6.7B5.6B6.2B6.2B
 
 
 
 
 
General Expenses4.3B4.0B4.4B4.0B
 
 
 
 
 
Other Operating Expenses0.0098.2M111.2M135.3M
 
 
 
 
Research And Development1.3B1.2B1.1B1.1B
 
 
 
 
 
Total Operating Expenses7.3B7.0B7.4B7.3B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income2.5B1.5B1.7B2.1B
 
 
 
 
 
Extraordinary Credit--13.2B10.8M4.6M
 
 
 
 
Extraordinary Charge-926.1M-1.0B-1.4B-865.8M
 
 
 
 
 
Interest Expense On Debt296.1M284.0M296.7M256.8M
 
 
 
 
 
Equity In Earnings17.3M34.7M-3.1M-3.1M
 
 
 
 
 
Other Expenses-412.7M1.5B227.1M313.7M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income819.0M15.0B238.0M1.3B
 
 
 
 
 
Income Taxes-778.1M-2.8B-57.2M-338.3M
 
 
 
 
 
Minority Interest-12.6M-77.0M-52.5M-167.6M
 
 
 
 
 
Net Income1.6B12.2B230.2M827.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS2.4B2.4B2.4B2.4B
 
 
 
 
 
Shares To Calculate EPS Diluted2.4B2.4B2.4B2.4B
 
 
 
 
 
 
Earnings Per ShareEPS$0.68$5.07$0.10$0.34
 
 
 
 
 
EPS Diluted$0.67$5.03$0.10$0.34